Correlation Between ATT and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both ATT and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Bolt Biotherapeutics, you can compare the effects of market volatilities on ATT and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Bolt Biotherapeutics.
Diversification Opportunities for ATT and Bolt Biotherapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ATT and Bolt is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of ATT i.e., ATT and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between ATT and Bolt Biotherapeutics
Taking into account the 90-day investment horizon ATT Inc is expected to generate 0.38 times more return on investment than Bolt Biotherapeutics. However, ATT Inc is 2.63 times less risky than Bolt Biotherapeutics. It trades about 0.05 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,724 in ATT Inc on August 28, 2024 and sell it today you would earn a total of 586.00 from holding ATT Inc or generate 33.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ATT Inc vs. Bolt Biotherapeutics
Performance |
| Timeline |
| ATT Inc |
| Bolt Biotherapeutics |
ATT and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATT and Bolt Biotherapeutics
The main advantage of trading using opposite ATT and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.| ATT vs. Liberty Broadband Srs | ATT vs. Ribbon Communications | ATT vs. Liberty Broadband Srs | ATT vs. Shenandoah Telecommunications Co |
| Bolt Biotherapeutics vs. Eliem Therapeutics | Bolt Biotherapeutics vs. Scpharmaceuticals | Bolt Biotherapeutics vs. Milestone Pharmaceuticals | Bolt Biotherapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |